2016 - Fellow of the American Association for the Advancement of Science (AAAS)
Surgery, Internal medicine, Cancer, Pathology and Cancer research are his primary areas of study. Dong M. Shin regularly links together related areas like Hazard ratio in his Surgery studies. His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His work on Cancer prevention as part of general Cancer study is frequently connected to Extramural, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His research integrates issues of Carcinogenesis and Head and neck cancer in his study of Pathology. His Cancer research research is multidisciplinary, relying on both Epidermal growth factor receptor, Oncogene, Chromatin, Growth factor receptor and In vivo.
His primary areas of study are Internal medicine, Cancer research, Cancer, Oncology and Head and neck cancer. His Internal medicine research integrates issues from Gastroenterology and Surgery. His studies in Surgery integrate themes in fields like Epidermoid carcinoma and Hazard ratio.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell culture, Cell growth, Cancer cell, Head and neck squamous-cell carcinoma and Apoptosis. His research investigates the connection between Cancer and topics such as Pathology that intersect with problems in Carcinogenesis. The concepts of his Head and neck cancer study are interwoven with issues in Disease and Epidermal growth factor receptor.
Dong M. Shin mostly deals with Internal medicine, Oncology, Cancer research, Cancer and Head and neck cancer. Dong M. Shin has researched Internal medicine in several fields, including Gastroenterology and Head and neck. His Oncology research also works with subjects such as
Dong M. Shin interconnects Cetuximab, Cell growth, Cancer cell, Kinase and In vivo in the investigation of issues within Cancer research. His work deals with themes such as Lung cancer and Carcinoma, which intersect with Cancer. His research on Head and neck cancer also deals with topics like
His primary areas of investigation include Cancer research, Cancer, Internal medicine, Oncology and Cancer cell. His Cancer research research is multidisciplinary, incorporating perspectives in Cell growth, Oncogene, Transcription factor, microRNA and Kinase. His Cancer study incorporates themes from Neuroendocrine tumors, Lymph node, Proportional hazards model and Lung.
His Proportional hazards model course of study focuses on Esophagectomy and Surgery. The various areas that Dong M. Shin examines in his Oncology study include Cetuximab, Head and neck squamous-cell carcinoma, Head and neck cancer, Carcinoma and Stage. His research integrates issues of Inflammation and Incidence in his study of Head and neck cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E Davis;Zhuo Georgia Chen;Dong M Shin.
Nature Reviews Drug Discovery (2008)
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
James A. Bonner;Paul M. Harari;Jordi Giralt;Nozar Azarnia.
The New England Journal of Medicine (2006)
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho;Xu Wang;Shuming Nie;Zhuo Georgia Chen.
Clinical Cancer Research (2008)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Marshall R. Posner;Diane M. Hershock;Cesar R. Blajman;Elizabeth Mickiewicz.
The New England Journal of Medicine (2007)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Recent Advances in Head and Neck Cancer
Robert I. Haddad;Dong M. Shin.
The New England Journal of Medicine (2008)
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
J. A. Roth;D. Nguyen;D. D. Lawrence;B. L. Kemp.
Nature Medicine (1996)
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha;Gloria J. Kim;Shuming Nie;Dong M. Shin.
Molecular Cancer Therapeutics (2006)
Application of Nanotechnology in Cancer Therapy and Imaging
Xu Wang;Lily Yang;Zhuo Georgia Chen;Dong M Shin.
CA: A Cancer Journal for Clinicians (2008)
Perspectives for Cancer Prevention With Natural Compounds
A.R.M. Ruhul Amin;Omer Kucuk;Fadlo R. Khuri;Dong M. Shin.
Journal of Clinical Oncology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: